Oralair Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

The oralair market research report is one of a series of new reports that provides oralair market statistics, including the oralair industry global market size, regional shares, competitors with the oralair market share, detailed oralair market segments, market trends, and opportunities, and any further data you may need to thrive in the oralair industry. This oralair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The growth in the forecast period can be attributed to the increasing prevalence of allergic conditions, growing demand for therapeutics, increase in the patient population, escalating demand for healthcare services, and increasing environmental pollution. Major trends in the forecast period include rising demand for personalized medicine, allergy testing advancements, shift to sublingual immunotherapy, growing interest in combining immunotherapy, and growing trend of self-medication.

The increasing prevalence of allergic conditions is expected to drive the growth of the Oralair market. Allergies occur when the immune system reacts to harmless substances, such as pollen, resulting in symptoms such as itching, swelling, and inflammation. This rise in allergic conditions is influenced by factors such as rising air pollution, environmental changes, and genetic factors. Oralair works by gradually desensitizing the immune system to allergens such as grass pollen, reducing sensitivity over time and providing long-term relief from allergic reactions. For example, in July 2024, the American Lung Association reported that in 2022, about one in three adults in the U.S. and more than one in four children had at least one allergic condition, including seasonal allergies, eczema, or food allergies. As the prevalence of allergies increases, the demand for Oralair continues to grow.

The increasing awareness of immunotherapy is expected to further propel the growth of the Oralair market. Immunotherapy is a treatment that enhances or modifies the immune system to fight diseases. The rising popularity of immunotherapy is driven by advancements in immune-based therapies and growing recognition of their effectiveness, along with a shift toward personalized medicine. Oralair functions as an allergy immunotherapy by desensitizing the immune system to grass pollen, offering a long-lasting treatment for allergic rhinitis. In June 2022, the National Library of Medicine reported that the U.S. Food and Drug Administration (FDA) authorized 35 new combination immunotherapies based on immune checkpoint inhibitors in 2022. This growing awareness and adoption of immunotherapy are contributing to the growth of the Oralair market.

Rising healthcare spending is also a significant factor driving the growth of the Oralair market. Healthcare spending refers to the financial resources allocated to medical services, treatments, and other healthcare needs. Increased healthcare spending is driven by an aging population, the rise of chronic diseases, advancements in medical technologies, and greater demand for healthcare services. As healthcare costs rise, both patients and providers are increasingly prioritizing long-term treatment solutions, making Oralair an attractive, cost-effective option for managing allergic rhinitis. For example, in November 2023, the Canadian Institute for Health Information projected that total healthcare spending in Canada would reach $344 billion in 2023, a 2.8% increase from the previous year. This growth in healthcare investment is further supporting the expansion of the Oralair market.

The key company operating in the oralair market are Stallergenes Greer.

Europe was the largest region in the oralair market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oralair report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oralair market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Oralair is an allergy immunotherapy treatment designed for grass pollen-induced allergic rhinitis, with or without conjunctivitis. It works by gradually desensitizing the immune system to grass pollen allergens, helping to reduce the severity of allergic reactions over time. As a long-term solution, it alleviates symptoms by progressively exposing the body to allergens, effectively managing grass pollen allergies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary indications for Oralair include allergic rhinitis, conjunctivitis, and allergic asthma. Allergic rhinitis is characterized by irritation of the nasal passages due to allergens, leading to symptoms such as sneezing, congestion, and a runny nose. Oralair is distributed through various channels, including pharmacies, hospitals, clinics, and specialty clinics, and is used by a wide range of end users, including adults, adolescents, and children.

The oralair market consists of sales of allergen extracts and sublingual tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.